NM_005677.4:c.1338C>A

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_005677.4(COLQ):​c.1338C>A​(p.Ile446Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00415 in 1,614,142 control chromosomes in the GnomAD database, including 198 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 89 hom., cov: 33)
Exomes 𝑓: 0.0024 ( 109 hom. )

Consequence

COLQ
NM_005677.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.58
Variant links:
Genes affected
COLQ (HGNC:2226): (collagen like tail subunit of asymmetric acetylcholinesterase) This gene encodes the subunit of a collagen-like molecule associated with acetylcholinesterase in skeletal muscle. Each molecule is composed of three identical subunits. Each subunit contains a proline-rich attachment domain (PRAD) that binds an acetylcholinesterase tetramer to anchor the catalytic subunit of the enzyme to the basal lamina. Mutations in this gene are associated with endplate acetylcholinesterase deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
EAF1-AS1 (HGNC:42328): (EAF1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BP6
Variant 3-15451674-G-T is Benign according to our data. Variant chr3-15451674-G-T is described in ClinVar as [Benign]. Clinvar id is 259855.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.58 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0681 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COLQNM_005677.4 linkc.1338C>A p.Ile446Ile synonymous_variant Exon 17 of 17 ENST00000383788.10 NP_005668.2 Q9Y215-1
COLQNM_080538.2 linkc.1308C>A p.Ile436Ile synonymous_variant Exon 17 of 17 NP_536799.1 Q9Y215-2
COLQNM_080539.4 linkc.1236C>A p.Ile412Ile synonymous_variant Exon 16 of 16 NP_536800.2 Q9Y215-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COLQENST00000383788.10 linkc.1338C>A p.Ile446Ile synonymous_variant Exon 17 of 17 1 NM_005677.4 ENSP00000373298.3 Q9Y215-1
COLQENST00000603808.5 linkc.1341C>A p.Ile447Ile synonymous_variant Exon 17 of 17 1 ENSP00000474271.1 A0A0C4DGS2
EAF1-AS1ENST00000629729.2 linkn.185C>A non_coding_transcript_exon_variant Exon 3 of 6 5 ENSP00000518887.1

Frequencies

GnomAD3 genomes
AF:
0.0209
AC:
3180
AN:
152180
Hom.:
89
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0703
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0122
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000382
Gnomad OTH
AF:
0.0167
GnomAD3 exomes
AF:
0.00582
AC:
1462
AN:
251324
Hom.:
50
AF XY:
0.00431
AC XY:
585
AN XY:
135866
show subpopulations
Gnomad AFR exome
AF:
0.0716
Gnomad AMR exome
AF:
0.00509
Gnomad ASJ exome
AF:
0.00437
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000229
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000414
Gnomad OTH exome
AF:
0.00407
GnomAD4 exome
AF:
0.00241
AC:
3521
AN:
1461846
Hom.:
109
Cov.:
31
AF XY:
0.00217
AC XY:
1576
AN XY:
727220
show subpopulations
Gnomad4 AFR exome
AF:
0.0734
Gnomad4 AMR exome
AF:
0.00586
Gnomad4 ASJ exome
AF:
0.00509
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000185
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000260
Gnomad4 OTH exome
AF:
0.00550
GnomAD4 genome
AF:
0.0209
AC:
3185
AN:
152296
Hom.:
89
Cov.:
33
AF XY:
0.0207
AC XY:
1538
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.0702
Gnomad4 AMR
AF:
0.0122
Gnomad4 ASJ
AF:
0.00490
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000382
Gnomad4 OTH
AF:
0.0166
Alfa
AF:
0.00247
Hom.:
3
Bravo
AF:
0.0241
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000415

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 06, 2017
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Congenital myasthenic syndrome 5 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 07, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.27
CADD
Benign
5.0
DANN
Benign
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs73818504; hg19: chr3-15493181; COSMIC: COSV67525589; COSMIC: COSV67525589; API